SEARCH
Boehringer Ingelheim investigational lung cancer treatment
CNW Group
2012-06-11
Views
45
Description
Share / Embed
Download This Video
Report
Boehringer Ingelheim's investigational lung cancer treatment afatinib* prolongs progression free survival (PFS) for advanced non-small cell lung cancer patients with specific EGFR genetic mutations.
http://cnw.ca/aYV1E
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/xrgn29" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
06:02
10 Unusual Genetic Mutations in Humans - Most Shocking Genetic Mutations in Peoples
04:36
Lupin To Develop Cancer Drug With Boehringer Ingelheim
02:57
Prognostic role of KRAS mutation in non-small-cell lung cancer - Eur. Lung Cancer Conference 201...
06:44
Screw You Cancer - Confronting Cancer: BRCA1 & BRCA2 Gene Mutations
01:10
Genetic mutations can give some humans 'superpowers'
05:39
10 REAL People With Shocking Genetic Mutations
01:06
Study Links Air Pollution and Infant Genetic Mutations
08:26
People with Real Super Powers, Genetic Mutations, and Body Alterations
12:12
Top 10 Real People With Genetic Mutations
05:39
10 REAL People With Shocking Genetic Mutations
01:27
Cancer du sein: les mutations génétiques identifiées
02:34
Les mutations génétiques du cancer du sein identifiées